期刊文献+

阿戈美拉汀的晶型制备表征及性质研究——药物多晶型综合设计性实验 被引量:3

Study on crystal preparation,characterization and property of Agomelatine:A comprehensive design experiment related to drug crystallization
下载PDF
导出
摘要 应用溶剂挥发、加入反溶剂、熔融等方法对固体药物阿戈美拉汀进行重结晶,能够得到3种晶型,分别使用红外光谱测定、差示扫描量热分析(DSC)、质谱(MS)等仪器分析方法进行表征,比较了所得晶型的稳定性以及溶解度等性质。该实验结合了化学与生物学热点问题,综合性较强,可作为大学本科综合实验的教学内容。 In this study,three crystal forms of solid drug Agomelatine were prepared by the methods of solvent evaporation,adding reverse solvent and melting.They were characterized by infrared spectrum,DSC analyses and ESI-MS.Moreover,their distinct melting points and solubilities were investigated.This experiment integrating chemical and biological hot issue is suitable to be designed as a comprehensive chemical experiment.
出处 《实验技术与管理》 CAS 北大核心 2015年第2期58-60,共3页 Experimental Technology and Management
基金 中山大学实验教学研究(改革)基金项目(YJ201317)
关键词 综合化学实验 晶型制备 仪器表征 性质比较 comprehensive chemical experiment crystal preparation instrument characterization property comparison
  • 相关文献

参考文献13

二级参考文献84

共引文献86

同被引文献53

  • 1冒莉,郑启泰,吕扬.固体药物多晶型的研究进展[J].天然产物研究与开发,2005,17(3):371-375. 被引量:48
  • 2宁黎丽.对药物研究中晶型问题的几点思考[J].药品评价,2007,4(4):304-306. 被引量:6
  • 3ZHANG Q,LU L,DAI W,et al.Polymorphism and isomorphism of huperzine A solvates:structure,properties and form transformation[J].Crystengcomm,2014,16(10):1919.
  • 4WANG JR,WANG X,LU L,et al.Highly crystalline forms of valsartan with superior physicochemical stability[J].Cryst Growth Design,2013,13(7):3261.
  • 5MA S,LIU H,JIAO H,et al.Neuroprotective effect of ginkgolide K on glutamate-induced cytotoxicity in PC 12 cells via inhibition of ROS generation and Ca(2+) influx[J].Neurotoxicology,2012,33(1):59.
  • 6MA S,LIU X,XUN Q,et al.Neuroprotective effect of ginkgolide K against H2O2-induced PC12 cell cytotoxicity by ameliorating mitochondrial dysfunction and oxidative stress[J].Biol Pharm Bull, 2014,37(2):217.
  • 7MA S,YIN H,CHEN L,et al.Neuroprotective effect of ginkgolide K against acute ischemic stroke on middle cerebral ischemia occlusion in rats[J].J Nat Med,2011,66(1):25.
  • 8WANG XY,GONG NB,YANG SY,et al.Studies on solvatomorphism of betulinic acid[J].J Pharm Sci,2014,103(9):2696.
  • 9BRITTAIN HG.Polymorphism and solvatomorphism[J].J Pharm Sci,2012,101(2):464.
  • 10中华人民共和国药典委员会.中国药典(一部)[S].北京:中国医药科技出版社,2015:32.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部